John Peter Wolf III

All filings by John Peter Wolf III on record concern Viropharma Inc. We count 42 filings; the first trade dates from 7 November 2011 and the latest from 24 January 2014.

Sales make up the whole of the open-market record (2 sales, €531k). The rest of the record consists of 13 share grants and 25 option exercises.

On 28 January 2014 came the latest disclosure, a transaction for €4.0M in Viropharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.